Tokyo, July 25 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058573) titled 'Artificial Intelligence-Assisted Reduction of Acquisition Time in 123I-Ioflupane Imaging: A Retrospective Single-Center Study' on July 25.
Study Type:
Observational
Primary Sponsor:
Institute - Yokohama City University Hospital
Condition:
Condition - Parkinsonism
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - We aim to investigate whether acquisition time can be reduced in SPECT/CT using ^123I-ioflupane by applying AI-based image reconstruction.
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients who underwent ^123I-ioflupane imaging
No age restriction
No sex restriction
Key exclusion criteria - Not applicalbe
Target Size - 207
Recruitment Status:
Recruitment status - Completed
Date of protocol fixation - 2019 Year 08 Month 30 Day
Date of IRB - 2019 Year 09 Month 19 Day
Anticipated trial start date - 2019 Year 09 Month 19 Day
Last follow-up date - 2026 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066547
Disclaimer: Curated by HT Syndication.
